Skip to content
Biodatica
Start free

Investigator

Kevin King

TURING MEDICAL TECHNOLOGIES INC · funded by NIA, NIMH, NINDS

Companies
2

Resolved onto their grants.

Grants
5

Federal awards on file.

Non-dilutive funding
$5.9M

Summed across those awards.

First award
Sep 20, 2022

Latest Sep 22, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R44

    Real-time head motion monitoring for all clinical MR sequences using Universal FIRMM

    $700k

    Sep 22, 2025NIATURING MEDICAL TECHNOLOGIES INCNIH RePORTER · 11254940 (opens the source filing in a new tab)

  2. SB1

    Commercialization readiness of motion-robust brain MRI for pediatric healthcare

    $1.3M

    Apr 15, 2024NIMHTURING MEDICAL TECHNOLOGIES INCNIH RePORTER · 11074617 (opens the source filing in a new tab)

  3. SB1

    Commercialization readiness of motion-robust brain MRI for pediatric healthcare

    $1.3M

    Apr 15, 2024NIMHTURING MEDICAL TECHNOLOGIES INCNIH RePORTER · 11330466 (opens the source filing in a new tab)

  4. SB1

    Framewise Integrated Real-Time MRI Monitoring (FIRMM) software commercialization readiness for clinical care

    $1.0M

    Apr 1, 2023NIMHTURING MEDICAL TECHNOLOGIES INCNIH RePORTER · 11047750 (opens the source filing in a new tab)

  5. R44

    Behavioral feedback and rewards for improving functional brain mapping in presurgical pediatric patients

    $1.5M

    Sep 20, 2022NINDSTURING MEDICAL TECHNOLOGIES INCNIH RePORTER · 11117053 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources